Skip to content
PubMed This is a summary of 42 peer-reviewed journal articles Updated
Dermatology

IgA Pemphigus: A Patient Guide

At a Glance

IgA pemphigus is a rare, noncontagious autoimmune skin condition that causes itchy pustules and blisters. Diagnosis usually requires a skin biopsy with direct immunofluorescence, and treatment often includes dapsone, corticosteroids, and ongoing monitoring.

Important Note: This guide is designed to help you understand your diagnosis and communicate effectively with your medical team. It does not replace an individualized dermatologist’s assessment. Never start, stop, or alter your doses of dapsone or systemic steroids without speaking to your prescriber.

If you have just been diagnosed with IgA Pemphigus, it is completely normal to feel overwhelmed. Many patients go through a long, confusing period of trying to find answers before arriving at this diagnosis. IgA pemphigus is an exceptionally rare autoimmune condition that primarily affects the skin, causing a distinctive rash of itchy, fluid-filled bumps called pustules (which contain inflammatory cells) and vesicles (which contain clear fluid).

Unlike common skin reactions or allergies, this disease occurs because the immune system mistakenly produces IgA antibodies that target the structural “glue” holding your skin cells together [1]. When this glue is attacked, the cells separate and fluid rushes in, creating the characteristic blisters and rings that can appear across the trunk, arms, and legs [2].

One of the most important things to understand is that although the white or yellow pustules can look like a bacterial infection, the condition is not contagious [3]. The fluid inside these bumps is usually “sterile,” meaning it is filled with your own inflammatory cells rather than bacteria or viruses. Because it is so rare—representing only a tiny fraction of all blistering diseases—reaching a diagnosis often involves a long journey of ruling out more common infections or other types of pemphigus [4].

Confirming the diagnosis requires a specialized set of tests beyond a standard skin check. Doctors must perform a specific type of biopsy called Direct Immunofluorescence (DIF), which uses a glowing dye to reveal the “chicken-wire” pattern of IgA antibodies trapped between the skin cells [5]. Identifying this specific antibody is the key to distinguishing IgA pemphigus from look-alike conditions and ensuring you receive the correct, tailored therapy [6].

Managing IgA pemphigus is a long-term commitment that focuses on calming the immune system’s overactive response. Treatment typically centers on medications like dapsone, which specifically blocks the inflammation that leads to pustules, often used alongside corticosteroids to quickly reduce flares [1]. While the condition is chronic and the disease course can be variable, many people find that with consistent monitoring and a specialized care team, the symptoms can be brought under control, allowing for a high quality of life [7].

Because this condition has occasionally been associated with other health changes—such as digestive issues or specific blood protein variations—your care may involve routine check-ups and individualized bloodwork [8]. This proactive evaluation is not routine cancer screening; rather, it is the standard way your doctors ensure that your entire body remains healthy while managing your skin. With a clear diagnosis finally in place, you can move away from the uncertainty of “what is this?” and toward a focused plan for healing and long-term stability.

Common questions in this guide

What does IgA pemphigus look like, and can I spread it to other people?
It typically causes an itchy rash made up of pustules, which contain inflammatory cells, and vesicles, which contain clear fluid. The bumps may form rings on the trunk, arms, or legs, but IgA pemphigus is an autoimmune condition rather than an infection and is not contagious.
How is IgA pemphigus confirmed?
Diagnosis requires a skin biopsy with direct immunofluorescence, a test that uses a fluorescent dye to look for IgA antibodies between skin cells. The characteristic intercellular pattern helps distinguish IgA pemphigus from infections and other blistering disorders.
What medicines are used to treat IgA pemphigus?
Dapsone is often central to treatment because it helps reduce the inflammation that forms pustules. Corticosteroids, including systemic steroids, may be used to bring flares under control, but these medicines should not be started, stopped, or changed without guidance from the prescriber.
Does IgA pemphigus go away, or is it a chronic condition?
IgA pemphigus is chronic, and its course can vary from person to person. With consistent treatment, monitoring, and care from an experienced team, many people can control symptoms and maintain a high quality of life.
Why might my doctor order blood tests or involve another specialist?
IgA pemphigus has occasionally been associated with digestive problems or changes in blood proteins, so clinicians may recommend individualized checkups or bloodwork. A hematologist may be consulted if blood-protein changes are a concern, and this evaluation is not routine cancer screening.

Get notified when new evidence is published on IgA pemphigus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    IgA pemphigus: A systematic review.

    Kridin K, Patel PM, Jones VA, et al.

    Journal of the American Academy of Dermatology 2020; (82(6)):1386-1392 doi:10.1016/j.jaad.2019.11.059.

    PMID: 31812619
  2. 2

    Clinical and immunological studies of 49 cases of various types of intercellular IgA dermatosis and 13 cases of classical subcorneal pustular dermatosis examined at Kurume University.

    Hashimoto T, Teye K, Ishii N

    The British journal of dermatology 2017; (176(1)):168-175 doi:10.1111/bjd.14780.

    PMID: 27258999
  3. 3

    Superficial and Bullous Neutrophilic Dermatoses: Sneddon-Wilkinson, IgA Pemphigus, and Bullous Lupus.

    Manjaly P, Sanchez K, Gregoire S, et al.

    Dermatologic clinics 2024; (42(2)):307-315 doi:10.1016/j.det.2023.08.010.

    PMID: 38423689
  4. 4

    A 14-year multicentric follow-up study of atypical pemphigus variants in Italy: the VARIANT_P study.

    Quintarelli L, Bonanni I, Mariotti EB, et al.

    Clinical and experimental dermatology 2026; (51(2)):250-262 doi:10.1093/ced/llaf438.

    PMID: 41072932
  5. 5

    State-of-the-art diagnosis of autoimmune blistering diseases.

    van Beek N, Holtsche MM, Atefi I, et al.

    Frontiers in immunology 2024; (15()):1363032 doi:10.3389/fimmu.2024.1363032.

    PMID: 38903493
  6. 6

    Diagnostic Utility of Direct Immunofluorescence on Paraffin-Embedded Skin Biopsy Samples for the Diagnosis of Autoimmune Vesiculobullous Lesions.

    Bk P, Panwar H, Joshi D, et al.

    Cureus 2024; (16(3)):e56916 doi:10.7759/cureus.56916.

    PMID: 38665766
  7. 7

    Case Report: A rare co-occurrence of IgA pemphigus and pyoderma gangrenosum associated with IgA-κ type monoclonal gammopathy of undetermined significance: a 19-year diagnostic and therapeutic journey.

    Xie Y, Liu X, Wu J, et al.

    Frontiers in immunology 2026; (17()):1832860 doi:10.3389/fimmu.2026.1832860.

    PMID: 42245644
  8. 8

    Subcorneal pustular dermatosis-type IgA pemphigus associated with multiple myeloma: A case report and literature review.

    Koga H, Tsutsumi M, Teye K, et al.

    The Journal of dermatology 2023; (50(2)):234-238 doi:10.1111/1346-8138.16516.

    PMID: 35838241

This guide explains IgA pemphigus for informational purposes and does not replace an individualized dermatologist’s assessment or medical advice. Do not start, stop, or change dapsone or systemic steroids without speaking with your prescriber.